UTMD Utah Medical Products, Inc.
Stable Earnings Power
B 69.6 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
C- 49
  • 5yr Avg ROIC 12.2%
  • Operating Margin Trend -2.24 pp/yr

Capital Efficiency

Weight: 15%
B+ 78
  • 5yr Avg ROE 12.5%
  • 5yr Share-Count CAGR -2.5%

Growth Quality

Weight: 15%
D- 30
  • 5yr Revenue CAGR -1.8%
  • 5yr EPS CAGR 3.4%
  • Revenue-Growth Years (5) 2/5

Cash Generation

Weight: 15%
A+ 98
  • 5yr FCF Margin 39.4%
  • 5yr FCF/NI Conversion 1.25x

Balance Sheet

Weight: 20%
A+ 100
  • Net Debt / EBITDA -5.01x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 43.73

Stability

Weight: 15%
C+ 57
  • EPS Volatility (σ/μ) 0.21
  • Negative-Revenue Years (5) 3/5
  • Piotroski F-Score 5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

1 of 1 gurus held.

Holders
1
Avg Δ position
0.0%
New buys
0
Full exits
0
As of Q2 2026